“Arbortext has long been a pioneer in XML authoring and publishing software,” said Ron Schmelzer, Senior Analyst at ZapThink. “Arbortext has shown that is able to offer high-quality, focused software to support every aspect of the drug development lifecycle – from discovery, clinical trials and regulatory approvals to manufacturing, marketing and medical affairs.”
Read more at: ArborText Press Release
Jason Bloomberg, President of ZapThink, will be delivering this two-day workshop in London on March 15 & 16, 2012, in partnership with IRM UK.
Click here for more information and to register!
In the News
Arbortext Focuses on Life Sciences
FREE POSTERS
ZapThink's Vision for Enterprise IT in 2020
10-pack of prints for just $29.95*
SOA Implementation Roadmap
10-pack of prints for just $29.95*
Copyright © 2012 ZapThink, a Dovèl Technologies Company. 
Discussion
No comments for “Arbortext Focuses on Life Sciences”